US Broker Ratings

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A 19% Potential Upside Attracts Investor Attention

Investors eyeing the healthcare sector might find Healthcare Services Group, Inc. (NASDAQ: HCSG) an intriguing proposition, as the company currently presents a potential upside of 19.05%. With a market capitalization..

Teladoc Health, Inc. (TDOC) Stock Analysis: Evaluating the 21.39% Potential Upside for Investors

As Teladoc Health, Inc. (NYSE: TDOC) continues to navigate the complex landscape of the healthcare sector, individual investors are keenly assessing its potential for future growth. With a market capitalization..

Mineralys Therapeutics (MLYS): Investor Outlook Reveals Nearly 30% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has emerged as a promising player in the biotechnology sector, captivating investor attention with its ambitious clinical initiatives and impressive stock performance. With a market..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Exploring a 28.66% Upside Potential in the Healthcare Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) is attracting considerable attention from investors, underpinned by a promising 28.66% potential upside. Operating at the forefront of the healthcare sector, BioLife Solutions is a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring Potential Upside with Healthcare Specialist

Pediatrix Medical Group, Inc. (NYSE: MD) stands at the forefront of neonatal and maternal-fetal healthcare in the United States, with a market capitalization of $1.88 billion. As a key player..

Evolent Health, Inc (EVH) Growth Potential: Analyst Consensus Points to 159% Upside

Evolent Health, Inc. (NYSE: EVH) is capturing attention across the investment community with its remarkable potential for substantial upside. With analyst ratings overwhelmingly favoring a “Buy” stance, the stock’s projected..

Evotec SE (EVO) Stock Analysis: Evaluating an 83.88% Potential Upside Despite Recent Challenges

For investors keen on exploring opportunities within the healthcare sector, Evotec SE (EVO), a prominent player in the drug discovery and development industry, presents a fascinating case. Situated in Hamburg,..

Novavax, Inc. (NVAX) Investor Outlook: Exploring an 86.82% Potential Upside in the Biotechnology Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has recently captured the attention of investors with its compelling potential upside of 86.82%, despite facing significant challenges. As..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a Potential 25.68% Upside in the Biotech Sector

For investors keen on the biotechnology sector, Liquidia Corporation (NASDAQ: LQDA) presents an intriguing opportunity with a potential upside of 25.68% according to current analyst ratings. As a biopharmaceutical company,..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Uncovering a 21.93% Potential Upside

Investors eyeing the healthcare sector should pay close attention to Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the specialty and generic drug manufacturing industry. Despite recent market volatility,..

agilon health, inc. (AGL) Stock Analysis: Navigating a 39% Potential Upside in Healthcare

agilon health, inc. (AGL) represents an intriguing prospect within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Westerville, Ohio, the company focuses on providing healthcare services..

Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 13.65% Potential Upside Amidst Steady Growth

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector’s medical instruments and supplies industry, has caught the eye of investors with its potential upside of 13.65%. With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Evaluating the 121.70% Revenue Growth in the Booming Biotech Market

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stands out in the biotechnology sector with its remarkable revenue growth and innovative approach to dermatological treatments. Headquartered in Westlake Village, California, this promising biopharmaceutical..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 33.7% Revenue Growth

Establishment Labs Holdings Inc (NASDAQ: ESTA), a prominent player in the healthcare sector specializing in medical devices, has been capturing attention with its impressive revenue growth and innovative product offerings...

Clover Health Investments (CLOV): A 26% Upside Potential in the Healthcare Plans Sector

Clover Health Investments, Corp. (NASDAQ: CLOV) is making waves in the healthcare plans sector with its innovative approach to Medicare Advantage plans. With a market capitalization of $1.32 billion, Clover..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Closer Look at Its 6.51% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a promising player in the biotechnology sector, has captured significant attention with its robust pipeline of novel oral small molecule therapeutics aimed at addressing chronic..

Omnicell, Inc. (OMCL): Investor Outlook Reveals Promising Upside Potential of 8.69%

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, is gaining traction among investors, bolstered by its robust performance metrics and growth potential. Specializing in health information services,..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing Growth with a Promising 146.70% Revenue Surge

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning name in the biotechnology sector, has been capturing investor attention with its impressive revenue growth and strategic focus on innovative therapeutic solutions, particularly..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 48.78% Potential Upside in the Competitive Ophthalmic Market

Investors looking for opportunities in the healthcare sector might find Harrow, Inc. (NASDAQ: HROW) an intriguing prospect, especially given its notable position in the ophthalmic pharmaceutical market. With a market..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and a 32.68% Potential Upside

Investors keeping an eye on the healthcare sector may find AtriCure, Inc. (NASDAQ: ATRC) an intriguing prospect. Known for its innovative medical instruments and supplies, AtriCure is a leader in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds